TOP NEWS: Astra Bevespi Aerosphere Trial Inconsistent With Prior Data
LONDON (Alliance News) - AstraZeneca PLC on Thursday said the 24-week Aeristo Phase IIIb trial for a fixed-dose dual bronchodilator Bevespi Aerosphere was inconsistent with previous trial aimed to Read More